Literature DB >> 7306859

Influence of serum protein, serum albumin concentrations and dose on midazolam anaesthesia induction times.

J G Reves, P Newfield, L R Smith.   

Abstract

Individual variation occurs in time to induction of anaesthesia with intravenous drugs. Less free drug is available to cross the blood-brain barrier when the drug is highly protein bound. Since this may prolong time to sleep, we correlated the induction time, serum albumin and total protein concentrations, and doses of midazolam, which is a highly protein bound intravenous anaesthetic. There is a poor correlation (r = 0.062) between induction time and serum protein, a weak (r = 0.542) but statistically significant (p = 0.026) correlation between induction time and serum albumin, and a highly significant (p = 0.003) negative correlation (r = 0.579) between drug dose and induction time. The administration of the appropriate dose of midazolam for induction, therefore, appears to affect induction time more significantly than does the serum albumin concentration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306859     DOI: 10.1007/bf03007152

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  13 in total

1.  Effects of plasma protein binding of drugs on duration and intensity of pharmacological activity.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1976-08       Impact factor: 3.534

Review 2.  Pharmacokinetics of drugs administered intravenously.

Authors:  C C Hug
Journal:  Anesth Analg       Date:  1978 Nov-Dec       Impact factor: 5.108

3.  A water-soluble benzodiazepine, RO21-3981, for induction of anesthesia.

Authors:  R J Fragen; F Gahl; N Caldwell
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

4.  Estimation of the multivariate logistic risk function: a comparison of the discriminant function and maximum likelihood approaches.

Authors:  M Halperin; W C Blackwelder; J I Verter
Journal:  J Chronic Dis       Date:  1971-07

5.  Drug-receptor reactions.

Authors:  J Norman
Journal:  Br J Anaesth       Date:  1979-07       Impact factor: 9.166

6.  New i.v. anaesthetics.

Authors:  J W Dundee
Journal:  Br J Anaesth       Date:  1979-07       Impact factor: 9.166

7.  The effective dose of midazolam.

Authors:  J G Reves; I Kissin; L R Smith
Journal:  Anesthesiology       Date:  1981-07       Impact factor: 7.892

8.  Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam.

Authors:  J G Reves; G Corssen; C Holcomb
Journal:  Can Anaesth Soc J       Date:  1978-05

9.  The relative potencies of thiopentone, ketamine, propanidid, alphaxalone and diazepam. A statistical study in man.

Authors:  L Stella; G Torri; C L Castiglioni
Journal:  Br J Anaesth       Date:  1979-02       Impact factor: 9.166

10.  RO 21-3981 for intravenous surgical premedication and induction of anesthesia.

Authors:  J T Conner; R L Katz; R R Pagano; C W Graham
Journal:  Anesth Analg       Date:  1978 Jan-Feb       Impact factor: 5.108

View more
  5 in total

1.  Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution.

Authors:  Jun Ohmori; Shigeru Maeda; Hitoshi Higuchi; Minako Ishii; Yukiko Arai; Yumiko Tomoyasu; Atsushi Kohjitani; Masahiko Shimada; Takuya Miyawaki
Journal:  J Anesth       Date:  2011-06-01       Impact factor: 2.078

2.  Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.

Authors:  Alison Edelman; Myrna Munar; Miriam R Elman; Dennis Koop; Ganesh Cherala
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

Review 3.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

Review 4.  Debate: Albumin administration should be avoided in the critically ill.

Authors:  T B Pulimood; G R Park
Journal:  Crit Care       Date:  2000       Impact factor: 9.097

Review 5.  Sedative and Analgesic Pharmacokinetics During Pediatric ECMO.

Authors:  Kanecia O Zimmerman; Samantha H Dallefeld; Christoph P Hornik; Kevin M Watt
Journal:  J Pediatr Pharmacol Ther       Date:  2020-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.